AI-Designed Drugs Break Through Barriers in Cancer and Alzheimer’s Treatment Researchers are now leveraging AI to design drugs that target the so-called “undruggable” proteins, unstable, shifting molecules that have evaded traditional therapies for decades. Why Protein Shape M... AI drug design Alzheimer's research biotechnology cancer therapy intrinsically disordered proteins medical innovation protein binders synthetic biology
Kitchen Compounds Show Promise for Boosting Brain Health, UC Irvine Study Finds Is the secret to a healthier, aging brain be found in your pantry? A new study from UC Irvine suggests that natural compounds, already present in common foods, might help fight the effects of aging an... aging Alzheimer's biomedical research brain health dietary supplements energy metabolism natural compounds neurodegeneration
Roche's Trontinemab Raises the Bar for Alzheimer's Amyloid Clearance Alzheimer’s disease treatments may be on the cusp of a major breakthrough, thanks to Roche’s innovative antibody, trontinemab . This next-generation therapy has shown remarkable speed and effectivenes... Alzheimer’s amyloid plaques blood-brain barrier clinical trials drug development neurodegeneration trontinemab
Unraveling the Gender Gap: Why Women Face a Higher Risk of Alzheimer’s Disease Alzheimer’s disease impacts women at nearly double the rate of men, prompting scientists to explore causes that go far beyond longer life expectancy. While a woman’s lifespan was once considered the m... Alzheimer's brain health genetics hormones hormone therapy menopause neurology women's health
Repurposed Cancer Drugs Show Promise Against Alzheimer’s Brain Damage Could the answer to reversing Alzheimer’s brain damage already exist on pharmacy shelves? Recent research points to a surprising possibility: some cancer drugs may help fight the devastating effects o... Alzheimer's brain health cancer drugs clinical trials drug repurposing gene expression irinotecan letrozole
GLP-1s: A Promising Frontier in Neurodegenerative Disease Treatment The recent surge in interest around GLP-1 receptor agonists has opened up exciting new avenues in medical science. Originally celebrated for their impact on diabetes and obesity, these medications are... Alzheimer’s brain health clinical trials GLP-1 neurodegeneration neuroprotection Parkinson’s
Predictive AI Models Could Upend Early Detection of Neurodegenerative Diseases What if a single MRI scan could reveal your risk for Alzheimer’s disease long before any symptoms emerge? As neurodegenerative conditions rise worldwide, innovative solutions are more critical than ev... AI in healthcare Alzheimer's disease early detection MRI imaging neurodegenerative diseases NSF research predictive modeling
AI Powers Precision Gene Delivery Systems For Brain and Spinal Cord Therapy Thanks to innovative gene delivery systems developed by NIH-funded teams, we may soon be able to deliver genetic instructions directly and precisely to select cells within the brain or spinal cord. Th... AAV vectors brain research gene therapy neurological disorders neuroscience NIH BRAIN Initiative precision medicine
Quality Sleep Can Help Defend Against Dementia in African Americans with Genetic Risk Imagine if something as simple as a restful night could help guard your brain against dementia, even if you're genetically predisposed. Groundbreaking research from Rutgers University–Newark suggests ... African Americans Alzheimer's disease brain health dementia prevention genetic risk personalized medicine sleep
Video Games Could Transform Early Detection of Alzheimer’s Disease Envision a world where playing a video game could reveal Alzheimer’s disease years before symptoms appear. Researchers at Rutgers-Newark are pioneering this possibility, developing computerized games ... Alzheimer's blood tests brain health clinical trials cognitive testing early detection inclusive research video games
Unlocking Alzheimer’s Mysteries: How PHGDH Changes the Game Alzheimer’s disease remains one of the most challenging neurodegenerative conditions, particularly in its late-onset form (LOAD), which strikes millions without clear genetic risk factors. Recent rese... Alzheimer's amyloid-beta biomarkers neurodegeneration PHGDH therapeutics transcriptional regulation
MIT Researchers Chart New Paths for Alzheimer’s Drug Targets Beyond Amyloid Alzheimer’s disease has challenged the scientific community for decades, especially as treatments focused on amyloid plaques have not delivered the hoped-for results. In a promising shift, researchers... Alzheimer's computational biology DNA repair drug discovery genetics MIT neurodegeneration RNA modification